4//SEC Filing
Driscoll Martin J 4
Accession 0001209191-17-047285
CIK 0001566373other
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 4:02 PM ET
Size
6.1 KB
Accession
0001209191-17-047285
Insider Transaction Report
Form 4
Driscoll Martin J
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2017-08-03$12.43/sh+1,000$12,430→ 54,400 total - Purchase
Common Stock
2017-08-03$12.28/sh+1,000$12,280→ 53,400 total
Documents
Issuer
Spring Bank Pharmaceuticals, Inc.
CIK 0001566373
Entity typeother
Related Parties
1- filerCIK 0001339402
Filing Metadata
- Form type
- 4
- Filed
- Aug 2, 8:00 PM ET
- Accepted
- Aug 3, 4:02 PM ET
- Size
- 6.1 KB